Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Small Cell × PT-100 dipeptide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Genitourinary 1 Endocrine 1

Conditions

Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Carcinoma, Small Cell 1

Interventions

Cisplatin 4 Etoposide 2 veliparib 1 sagopilone 1 sacituzumab govitecan 1 pomalidomide 1 pembrolizumab 1 etoposide phosphate 1 Rhenium 1 Radiation 1 Podophyllotoxin 1 Platinum 1 Penfluridol 1 Pemetrexed 1 PT-100 dipeptide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03910660 2025-10-20

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

BioXcel Therapeutics Inc

Phase 1/2 Completed

EndocrineGenitourinaryNET

Prostatic Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡